vs

Side-by-side financial comparison of Alight, Inc. (ALIT) and CABOT CORP (CBT). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $653.0M, roughly 1.3× Alight, Inc.). CABOT CORP runs the higher net margin — 8.6% vs -142.7%, a 151.3% gap on every dollar of revenue. On growth, Alight, Inc. posted the faster year-over-year revenue change (-4.0% vs -11.1%). Alight, Inc. produced more free cash flow last quarter ($99.0M vs $57.0M). Over the past eight quarters, Alight, Inc.'s revenue compounded faster (8.1% CAGR vs -8.7%).

Alight Solutions is an American information technology and consulting company that provides cloud-based systems, outsourcing and consultancy related to human resource. They provide platforms and outsourcing for large companies to manage their human capital this includes health benefit administration, financial management and retirement planning.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

ALIT vs CBT — Head-to-Head

Bigger by revenue
CBT
CBT
1.3× larger
CBT
$849.0M
$653.0M
ALIT
Growing faster (revenue YoY)
ALIT
ALIT
+7.1% gap
ALIT
-4.0%
-11.1%
CBT
Higher net margin
CBT
CBT
151.3% more per $
CBT
8.6%
-142.7%
ALIT
More free cash flow
ALIT
ALIT
$42.0M more FCF
ALIT
$99.0M
$57.0M
CBT
Faster 2-yr revenue CAGR
ALIT
ALIT
Annualised
ALIT
8.1%
-8.7%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALIT
ALIT
CBT
CBT
Revenue
$653.0M
$849.0M
Net Profit
$-932.0M
$73.0M
Gross Margin
36.8%
24.9%
Operating Margin
-114.9%
15.2%
Net Margin
-142.7%
8.6%
Revenue YoY
-4.0%
-11.1%
Net Profit YoY
-11750.0%
-21.5%
EPS (diluted)
$-1.77
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALIT
ALIT
CBT
CBT
Q4 25
$653.0M
$849.0M
Q3 25
$533.0M
$899.0M
Q2 25
$528.0M
$923.0M
Q1 25
$548.0M
$936.0M
Q4 24
$680.0M
$955.0M
Q3 24
$555.0M
$1.0B
Q2 24
$538.0M
$1.0B
Q1 24
$559.0M
$1.0B
Net Profit
ALIT
ALIT
CBT
CBT
Q4 25
$-932.0M
$73.0M
Q3 25
$-1.1B
$43.0M
Q2 25
$-1.1B
$101.0M
Q1 25
$-25.0M
$94.0M
Q4 24
$8.0M
$93.0M
Q3 24
$-74.0M
$137.0M
Q2 24
$23.0M
$109.0M
Q1 24
$-114.0M
$84.0M
Gross Margin
ALIT
ALIT
CBT
CBT
Q4 25
36.8%
24.9%
Q3 25
33.4%
24.5%
Q2 25
33.3%
26.4%
Q1 25
31.2%
25.7%
Q4 24
39.9%
24.6%
Q3 24
31.4%
24.0%
Q2 24
31.0%
25.2%
Q1 24
32.6%
24.1%
Operating Margin
ALIT
ALIT
CBT
CBT
Q4 25
-114.9%
15.2%
Q3 25
-248.0%
15.2%
Q2 25
-191.3%
18.1%
Q1 25
-1.5%
17.3%
Q4 24
6.5%
16.2%
Q3 24
-7.6%
15.0%
Q2 24
-9.7%
16.9%
Q1 24
-7.2%
15.3%
Net Margin
ALIT
ALIT
CBT
CBT
Q4 25
-142.7%
8.6%
Q3 25
-200.2%
4.8%
Q2 25
-203.2%
10.9%
Q1 25
-4.6%
10.0%
Q4 24
1.2%
9.7%
Q3 24
-13.3%
13.7%
Q2 24
4.3%
10.7%
Q1 24
-20.4%
8.2%
EPS (diluted)
ALIT
ALIT
CBT
CBT
Q4 25
$-1.77
$1.37
Q3 25
$-2.02
$0.80
Q2 25
$-2.03
$1.86
Q1 25
$-0.05
$1.69
Q4 24
$0.02
$1.67
Q3 24
$-0.14
$2.41
Q2 24
$0.04
$1.94
Q1 24
$-0.21
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALIT
ALIT
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$273.0M
$230.0M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$1.0B
$1.6B
Total Assets
$4.6B
$3.8B
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALIT
ALIT
CBT
CBT
Q4 25
$273.0M
$230.0M
Q3 25
$205.0M
$258.0M
Q2 25
$227.0M
$239.0M
Q1 25
$223.0M
$213.0M
Q4 24
$343.0M
$183.0M
Q3 24
$300.0M
$223.0M
Q2 24
$183.0M
$197.0M
Q1 24
$256.0M
$206.0M
Total Debt
ALIT
ALIT
CBT
CBT
Q4 25
$2.0B
Q3 25
$2.0B
$1.1B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
$1.1B
Q2 24
$2.8B
Q1 24
$2.8B
Stockholders' Equity
ALIT
ALIT
CBT
CBT
Q4 25
$1.0B
$1.6B
Q3 25
$2.0B
$1.6B
Q2 25
$3.1B
$1.5B
Q1 25
$4.2B
$1.4B
Q4 24
$4.3B
$1.4B
Q3 24
$4.3B
$1.4B
Q2 24
$4.5B
$1.3B
Q1 24
$4.5B
$1.4B
Total Assets
ALIT
ALIT
CBT
CBT
Q4 25
$4.6B
$3.8B
Q3 25
$5.5B
$3.8B
Q2 25
$6.8B
$3.8B
Q1 25
$7.9B
$3.8B
Q4 24
$8.2B
$3.6B
Q3 24
$8.3B
$3.7B
Q2 24
$10.5B
$3.6B
Q1 24
$10.7B
$3.6B
Debt / Equity
ALIT
ALIT
CBT
CBT
Q4 25
1.92×
Q3 25
1.00×
0.70×
Q2 25
0.65×
Q1 25
0.48×
Q4 24
0.47×
Q3 24
0.47×
0.75×
Q2 24
0.62×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALIT
ALIT
CBT
CBT
Operating Cash FlowLast quarter
$124.0M
$126.0M
Free Cash FlowOCF − Capex
$99.0M
$57.0M
FCF MarginFCF / Revenue
15.2%
6.7%
Capex IntensityCapex / Revenue
3.8%
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$250.0M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALIT
ALIT
CBT
CBT
Q4 25
$124.0M
$126.0M
Q3 25
$77.0M
$219.0M
Q2 25
$86.0M
$249.0M
Q1 25
$73.0M
$73.0M
Q4 24
$118.0M
$124.0M
Q3 24
$-24.0M
$204.0M
Q2 24
$58.0M
$207.0M
Q1 24
$100.0M
$176.0M
Free Cash Flow
ALIT
ALIT
CBT
CBT
Q4 25
$99.0M
$57.0M
Q3 25
$49.0M
$155.0M
Q2 25
$58.0M
$188.0M
Q1 25
$44.0M
$1.0M
Q4 24
$92.0M
$47.0M
Q3 24
$-52.0M
$112.0M
Q2 24
$22.0M
$155.0M
Q1 24
$69.0M
$133.0M
FCF Margin
ALIT
ALIT
CBT
CBT
Q4 25
15.2%
6.7%
Q3 25
9.2%
17.2%
Q2 25
11.0%
20.4%
Q1 25
8.0%
0.1%
Q4 24
13.5%
4.9%
Q3 24
-9.4%
11.2%
Q2 24
4.1%
15.3%
Q1 24
12.3%
13.1%
Capex Intensity
ALIT
ALIT
CBT
CBT
Q4 25
3.8%
8.1%
Q3 25
5.3%
7.1%
Q2 25
5.3%
6.6%
Q1 25
5.3%
7.7%
Q4 24
3.8%
8.1%
Q3 24
5.0%
9.2%
Q2 24
6.7%
5.1%
Q1 24
5.5%
4.2%
Cash Conversion
ALIT
ALIT
CBT
CBT
Q4 25
1.73×
Q3 25
5.09×
Q2 25
2.47×
Q1 25
0.78×
Q4 24
14.75×
1.33×
Q3 24
1.49×
Q2 24
2.52×
1.90×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALIT
ALIT

Recurring$607.0M93%
Projects$46.0M7%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons